FDA issued a Warning Letter to OHM Pharma, Inc. on 11/19/2019 as a result of this inspection.
FDA investigators audited the OHM Pharma - Mineral Wells, TX, United States facility and issued inspectional observations (via FDA 483) on 23 May 2019.
Product details
- Category: Human Drugs
- Inspection end: 23 May 2019
- Location: Mineral Wells, United States
- FEI: 3003231743
